Dr Reddy's is planning to acquire the specialty injectable company OctoPlus for approximately EUR 27.4 million ($35.7 million) in cash to strengthen its technological capabilities in drug delivery. Dr ...
The offer is expected to be launched in mid December and will run for a period of eight weeks to 10 weeks. The offer is expected to be launched in mid December and will run for a period of eight weeks ...
The country's second largest drugmaker Dr. Reddy's Laboratories, is set to acquire Octopus, a Netherlands-based specialty pharmaceutical company for €27.4 million as part of its plan to expand its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback